 |
|
|
 | GlaxoSmithKline PLC (NYSE:GSK) | 7/28/2010 |  |
| THURSDAY, JULY 29, 2010 | | 7:00 AM | Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease - PR Newswire |  | | 6:00 AM | Aptuit and Siena Biotech Announce Strategic Relationship in Italy - BusinessWire |  | | TUESDAY, JULY 27, 2010 | | 10:15 AM | NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline - BusinessWire |  | | 9:05 AM | GlaxoSmithKline to enforce new customer compensation system for US sales professionals - M2 |  | | MONDAY, JULY 26, 2010 | | 6:44 PM | GlaxoSmithKline, Johnson & Johnson, Pfizer, AstraZeneca and More Present at the 6th Compound Management & Integrity Conference in Philadelphia, PA - BusinessWire |  | | 3:00 PM | GlaxoSmithKline to Implement New Compensation Program for U.S. Sales Professionals - PR Newswire |  | | THURSDAY, JULY 22, 2010 | | 12:26 PM | NPC Welcomes GlaxoSmithKline as New Member - PR Newswire |  | | 8:30 AM | Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference - PR Newswire |  | | WEDNESDAY, JULY 21, 2010 | | 3:00 PM | Actavis Receives Approval of Bupropion HCl SR 100mg and 200mg in the U.S. - PR Newswire |  | | 1:12 PM | Pharmaceutical, Biotech and Guidance Agencies including GlaxoSmithKline, Noven Pharmaceuticals Inc., Roche Carolina, Pfizer, Eli Lilly, Abbott and More Will Convene to Discuss the Latest in PAT & QbD Initiatives - BusinessWire |  |
|
|
 |